Reports suggest that Nordic Capital- and Blackstone-backed pharmaceuticals business Nycomed has made a takeover approach for the drug division of publicly listed chemical and pharmaceutical company Solvay SA, with the offer thought to be valued at around EUR 4.5bn.
BCEP II follows a long-hold private equity strategy, with an investment period of 15 years
Combined companies will pursue a buy-and-build strategy, acquiring fitness studio chains
Marc Seeger joins the firm's Düsseldorf-based corporate and M&A team from Hengeler Mueller
GP acquires the automotive networked systems business as part of a succession solution